• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,094
80
61
58
47

COUNTRY

56
17
8
6
5

CATEGORIES

  • 89
  • 129
  • 72
  • 72
  • 43
  • 43
  • 21
  • 16
  • 20
  • 22

PRICE

547
798
1,611
2,578

PUBLISHED

82
298
723
2,578

PRODUCT TYPE

2,432
71
62
12
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hormone Refractory (Castration Resistant,...

March 2014
FROM

Fibrosarcoma Global Clinical Trials Review, H1, 2014

Fibrosarcoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Fibrosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Fibrosarcoma clinical trial scenario....

March 2014
FROM

Brenner Tumor Global Clinical Trials Review, H1, 2014

Brenner Tumor Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2014" provides data on the Brenner Tumor clinical trial scenario....

March 2014
FROM

Colon Cancer Global Clinical Trials Review, H1, 2014

Colon Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Colon Cancer Global Clinical Trials Review, H1, 2014" provides data on the Colon Cancer clinical trial scenario....

March 2014
FROM

Duodenal Cancer Global Clinical Trials Review, H1, 2014

Duodenal Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Duodenal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Duodenal Cancer clinical trial...

March 2014
FROM

Chondrosarcoma Global Clinical Trials Review, H1, 2014

Chondrosarcoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chondrosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Chondrosarcoma clinical trial...

March 2014
FROM

Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014

Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the...

March 2014
FROM

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2014

Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Choriocarcinoma (Gestational Trophoblastic Neoplasia) Global Clinical...

March 2014
FROM

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)...

March 2014
FROM

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global...

March 2014
FROM

US Personalized Cancer Genome Sequencing Market Outlook 2018

The whole genome sequencing technology, over the past decade, has developed at an unprecedented rate There has been a rapid progression from targeted gene sequencing to targeted whole genome sequencing...

March 2014
FROM

The Corporate Reputation of Pharma - The Patient Perspective (Cancer)

- A global survey, conducted mid-November to mid-December 2013 - The views of 140 patient groups with an interest in cancer from 29 countries - Feedback on the corporate reputation of 17 pharma companies...

March 2014
FROM
Competitor Analysis: Cancer Vaccines Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of March 2014 Purchase...

March 2014
FROM

Leiomyosarcoma Global Clinical Trials Review, H1, 2014

Leiomyosarcoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial...

February 2014
FROM

Fallopian Tube Cancer - Pipeline Review, H1 2014

Fallopian Tube Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2014’, provides an overview of the Fallopian Tube Cancer’s therapeutic...

February 2014
FROM

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant,...

February 2014
FROM

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H1 2014’, provides an overview of the Neuro...

February 2014
FROM

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014

Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Hepatocellular Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Hepatocellular...

February 2014
FROM

Indolent Lymphoma Global Clinical Trials Review, H1, 2014

Indolent Lymphoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the Indolent Lymphoma clinical...

February 2014
FROM

Brain Tumor - Pipeline Review, H1 2014

Brain Tumor - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Tumor - Pipeline Review, H1 2014’, provides an overview of the Brain Tumor’s therapeutic pipeline. This report provides...

February 2014
FROM
Loading Indicator

Our Clients

Our clients' logos